1. Home
  2. NAMS vs CCU Comparison

NAMS vs CCU Comparison

Compare NAMS & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • CCU
  • Stock Information
  • Founded
  • NAMS 2019
  • CCU 1850
  • Country
  • NAMS Netherlands
  • CCU Chile
  • Employees
  • NAMS N/A
  • CCU N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • CCU Beverages (Production/Distribution)
  • Sector
  • NAMS Health Care
  • CCU Consumer Staples
  • Exchange
  • NAMS Nasdaq
  • CCU Nasdaq
  • Market Cap
  • NAMS 2.7B
  • CCU 2.3B
  • IPO Year
  • NAMS N/A
  • CCU 1992
  • Fundamental
  • Price
  • NAMS $18.57
  • CCU $12.96
  • Analyst Decision
  • NAMS Strong Buy
  • CCU Strong Sell
  • Analyst Count
  • NAMS 7
  • CCU 2
  • Target Price
  • NAMS $41.33
  • CCU $9.70
  • AVG Volume (30 Days)
  • NAMS 646.5K
  • CCU 114.4K
  • Earning Date
  • NAMS 03-04-2025
  • CCU 02-25-2025
  • Dividend Yield
  • NAMS N/A
  • CCU 3.23%
  • EPS Growth
  • NAMS N/A
  • CCU 16.02
  • EPS
  • NAMS N/A
  • CCU 0.39
  • Revenue
  • NAMS $33,594,000.00
  • CCU $2,795,960,314.00
  • Revenue This Year
  • NAMS $131.53
  • CCU $8.10
  • Revenue Next Year
  • NAMS N/A
  • CCU $6.92
  • P/E Ratio
  • NAMS N/A
  • CCU $16.86
  • Revenue Growth
  • NAMS 78.77
  • CCU N/A
  • 52 Week Low
  • NAMS $15.19
  • CCU $10.00
  • 52 Week High
  • NAMS $27.29
  • CCU $13.74
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 29.65
  • CCU 66.34
  • Support Level
  • NAMS $18.88
  • CCU $12.57
  • Resistance Level
  • NAMS $20.46
  • CCU $13.08
  • Average True Range (ATR)
  • NAMS 1.11
  • CCU 0.24
  • MACD
  • NAMS -0.09
  • CCU 0.02
  • Stochastic Oscillator
  • NAMS 5.84
  • CCU 86.67

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Share on Social Networks: